These effects, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the strategy of focusing on ACKR3 as a unique approach to modulate the opioid method, which could open new therapeutic avenues for opioid-related Problems. Disclaimer: The above mentioned is https://johns368nhz4.mdkblog.com/profile